Search Results
Management & outcome of patients with CBF AML and FLT3-ITD
The impact of cytogenetics on treatment decisions in AML
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
Prognostic impact of FLT3-ITD in older patients with AML
What Is FLT3-Mutated Acute Myeloid Leukemia?
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations
Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
Understanding the molecular complexity of AML
Investigating the molecular and clinical features of FLT3-JMD mutations in AML
Further analysis of QuANTUM-First: the impact of allo-HCT combined with quizartinib in FLT3-ITD+ AML
FLT3 mutational status can change between diagnosis and relapse in patients with AML
GO plus midostaurin and intensive chemotherapy in CBF and FLT-mut AML
